US Stock MarketDetailed Quotes

MEIP MEI Pharma

Watchlist
  • 2.7800
  • -0.0300-1.07%
Close Nov 22 16:00 ET
  • 2.7800
  • 0.00000.00%
Post 20:01 ET
18.52MMarket Cap-397P/E (TTM)

MEI Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Sep 30, 2024
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
(Q2)Dec 31, 2023
(Q1)Sep 30, 2023
(FY)Jun 30, 2023
(Q4)Jun 30, 2023
(Q3)Mar 31, 2023
(Q2)Dec 31, 2022
Total revenue
0
33.76%65.3M
0
0
0
647.96%65.3M
19.95%48.82M
-87.23%1.46M
-39.20%5.89M
176.66%32.74M
Operating revenue
--0
33.76%65.3M
--0
--0
--0
647.96%65.3M
19.95%48.82M
-87.23%1.46M
-39.20%5.89M
176.66%32.74M
Cost of revenue
Gross profit
Operating expense
-16.61%8.35M
-53.43%39.86M
-35.54%8.08M
-55.89%9.83M
-49.89%11.93M
-62.83%10.02M
-26.34%85.58M
-54.59%12.54M
-28.69%22.29M
-19.17%23.81M
Selling and administrative expenses
-20.55%5.19M
-29.69%23.3M
-58.49%4.14M
-35.82%4.61M
-5.63%8.02M
-12.76%6.53M
8.48%33.13M
72.71%9.97M
-19.62%7.18M
7.19%8.5M
-General and administrative expense
-20.55%5.19M
-29.69%23.3M
-58.49%4.14M
-35.82%4.61M
-5.63%8.02M
-12.76%6.53M
8.48%33.13M
72.71%9.97M
-19.62%7.18M
7.19%8.5M
Research and development costs
-9.24%3.16M
-68.43%16.56M
53.46%3.94M
-65.44%5.22M
-74.45%3.91M
-82.09%3.49M
-38.76%52.45M
-88.23%2.57M
-32.32%15.1M
-28.88%15.31M
Operating profit
-115.11%-8.35M
169.20%25.44M
27.07%-8.08M
40.03%-9.83M
-233.65%-11.93M
403.42%55.28M
51.30%-36.76M
31.59%-11.08M
23.97%-16.39M
150.64%8.93M
Net non-operating interest income expense
-67.55%355K
-2.03%3.28M
-42.80%608K
-26.23%706K
2.84%869K
127.92%1.09M
1,077.82%3.35M
416.02%1.06M
1,495.00%957K
7,581.82%845K
Non-operating interest income
-67.55%355K
-2.03%3.28M
-42.80%608K
-26.23%706K
2.84%869K
127.92%1.09M
1,077.82%3.35M
416.02%1.06M
1,495.00%957K
7,581.82%845K
Other net income (expense)
-900.00%-10K
-791.97%-10.94M
-91,008.33%-10.93M
0.00%-4K
-100.41%-2K
-100.09%-1K
-92.38%1.58M
83.56%-12K
-100.03%-4K
-91.17%482K
Gain on sale of security
----
----
----
----
----
----
-92.28%1.6M
--0
----
-91.10%486K
Special income (charges)
----
---10.9M
----
----
----
----
--0
----
----
----
-Less:Impairment of capital assets
----
--10.9M
----
----
----
----
--0
----
----
----
Other non- operating income (expenses)
-900.00%-10K
-86.36%-41K
-183.33%-34K
0.00%-4K
50.00%-2K
50.00%-1K
-266.67%-22K
---12K
---4K
---4K
Income before tax
-114.20%-8.01M
155.84%17.78M
-83.53%-18.41M
40.88%-9.13M
-207.90%-11.06M
439.11%56.37M
41.53%-31.84M
37.56%-10.03M
-76.94%-15.44M
184.35%10.25M
Income tax
Net income
-114.20%-8.01M
155.84%17.78M
-83.53%-18.41M
40.88%-9.13M
-207.90%-11.06M
439.11%56.37M
41.53%-31.84M
37.56%-10.03M
-76.94%-15.44M
184.35%10.25M
Net income continuous Operations
-114.20%-8.01M
155.84%17.78M
-83.53%-18.41M
40.88%-9.13M
-207.90%-11.06M
439.11%56.37M
41.53%-31.84M
37.56%-10.03M
-76.94%-15.44M
184.35%10.25M
Minority interest income
Net income attributable to the parent company
-114.20%-8.01M
155.84%17.78M
-83.53%-18.41M
40.88%-9.13M
-207.90%-11.06M
439.11%56.37M
41.53%-31.84M
37.56%-10.03M
-76.94%-15.44M
184.35%10.25M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-114.20%-8.01M
155.84%17.78M
-83.53%-18.41M
40.88%-9.13M
-207.90%-11.06M
439.11%56.37M
41.53%-31.84M
37.56%-10.03M
-76.94%-15.44M
184.35%10.25M
Basic earnings per share
-114.18%-1.2
155.86%2.67
-82.78%-2.76
40.95%-1.37
-207.79%-1.66
439.76%8.46
45.37%-4.78
38.11%-1.51
-77.10%-2.32
177.00%1.54
Diluted earnings per share
-114.18%-1.2
155.86%2.67
-82.78%-2.76
40.95%-1.37
-207.79%-1.66
439.76%8.46
52.15%-4.78
38.11%-1.51
-77.10%-2.32
155.00%1.54
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Sep 30, 2024(FY)Jun 30, 2024(Q4)Jun 30, 2024(Q3)Mar 31, 2024(Q2)Dec 31, 2023(Q1)Sep 30, 2023(FY)Jun 30, 2023(Q4)Jun 30, 2023(Q3)Mar 31, 2023(Q2)Dec 31, 2022
Total revenue 033.76%65.3M000647.96%65.3M19.95%48.82M-87.23%1.46M-39.20%5.89M176.66%32.74M
Operating revenue --033.76%65.3M--0--0--0647.96%65.3M19.95%48.82M-87.23%1.46M-39.20%5.89M176.66%32.74M
Cost of revenue
Gross profit
Operating expense -16.61%8.35M-53.43%39.86M-35.54%8.08M-55.89%9.83M-49.89%11.93M-62.83%10.02M-26.34%85.58M-54.59%12.54M-28.69%22.29M-19.17%23.81M
Selling and administrative expenses -20.55%5.19M-29.69%23.3M-58.49%4.14M-35.82%4.61M-5.63%8.02M-12.76%6.53M8.48%33.13M72.71%9.97M-19.62%7.18M7.19%8.5M
-General and administrative expense -20.55%5.19M-29.69%23.3M-58.49%4.14M-35.82%4.61M-5.63%8.02M-12.76%6.53M8.48%33.13M72.71%9.97M-19.62%7.18M7.19%8.5M
Research and development costs -9.24%3.16M-68.43%16.56M53.46%3.94M-65.44%5.22M-74.45%3.91M-82.09%3.49M-38.76%52.45M-88.23%2.57M-32.32%15.1M-28.88%15.31M
Operating profit -115.11%-8.35M169.20%25.44M27.07%-8.08M40.03%-9.83M-233.65%-11.93M403.42%55.28M51.30%-36.76M31.59%-11.08M23.97%-16.39M150.64%8.93M
Net non-operating interest income expense -67.55%355K-2.03%3.28M-42.80%608K-26.23%706K2.84%869K127.92%1.09M1,077.82%3.35M416.02%1.06M1,495.00%957K7,581.82%845K
Non-operating interest income -67.55%355K-2.03%3.28M-42.80%608K-26.23%706K2.84%869K127.92%1.09M1,077.82%3.35M416.02%1.06M1,495.00%957K7,581.82%845K
Other net income (expense) -900.00%-10K-791.97%-10.94M-91,008.33%-10.93M0.00%-4K-100.41%-2K-100.09%-1K-92.38%1.58M83.56%-12K-100.03%-4K-91.17%482K
Gain on sale of security -------------------------92.28%1.6M--0-----91.10%486K
Special income (charges) -------10.9M------------------0------------
-Less:Impairment of capital assets ------10.9M------------------0------------
Other non- operating income (expenses) -900.00%-10K-86.36%-41K-183.33%-34K0.00%-4K50.00%-2K50.00%-1K-266.67%-22K---12K---4K---4K
Income before tax -114.20%-8.01M155.84%17.78M-83.53%-18.41M40.88%-9.13M-207.90%-11.06M439.11%56.37M41.53%-31.84M37.56%-10.03M-76.94%-15.44M184.35%10.25M
Income tax
Net income -114.20%-8.01M155.84%17.78M-83.53%-18.41M40.88%-9.13M-207.90%-11.06M439.11%56.37M41.53%-31.84M37.56%-10.03M-76.94%-15.44M184.35%10.25M
Net income continuous Operations -114.20%-8.01M155.84%17.78M-83.53%-18.41M40.88%-9.13M-207.90%-11.06M439.11%56.37M41.53%-31.84M37.56%-10.03M-76.94%-15.44M184.35%10.25M
Minority interest income
Net income attributable to the parent company -114.20%-8.01M155.84%17.78M-83.53%-18.41M40.88%-9.13M-207.90%-11.06M439.11%56.37M41.53%-31.84M37.56%-10.03M-76.94%-15.44M184.35%10.25M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -114.20%-8.01M155.84%17.78M-83.53%-18.41M40.88%-9.13M-207.90%-11.06M439.11%56.37M41.53%-31.84M37.56%-10.03M-76.94%-15.44M184.35%10.25M
Basic earnings per share -114.18%-1.2155.86%2.67-82.78%-2.7640.95%-1.37-207.79%-1.66439.76%8.4645.37%-4.7838.11%-1.51-77.10%-2.32177.00%1.54
Diluted earnings per share -114.18%-1.2155.86%2.67-82.78%-2.7640.95%-1.37-207.79%-1.66439.76%8.4652.15%-4.7838.11%-1.51-77.10%-2.32155.00%1.54
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data